{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:02:51Z","timestamp":1762542171426},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Supplement 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7,1]]},"DOI":"10.1097\/qai.0b013e31829a3a4d","type":"journal-article","created":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T18:41:26Z","timestamp":1371062486000},"page":"S183-S186","source":"Crossref","is-referenced-by-count":22,"title":["Preparing for the Unexpected"],"prefix":"10.1097","volume":"63","author":[{"given":"Beryl A.","family":"Koblin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Andrasik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judy","family":"Austin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-14-20210131","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":". Prevention of HIV-1 infection with early antiretroviral therapy.","volume":"365","author":"Cohen","year":"2011","journal-title":"N Engl J Med"},{"key":"R2-14-20210131","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1371\/journal.pmed.0020298","article-title":". Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.","volume":"2","author":"Auvert","year":"2005","journal-title":"PLoS Med"},{"key":"R3-14-20210131","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0140-6736(07)60312-2","article-title":". Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.","volume":"369","author":"Bailey","year":"2007","journal-title":"Lancet"},{"key":"R4-14-20210131","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(07)60313-4","article-title":". Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.","volume":"369","author":"Gray","year":"2007","journal-title":"Lancet"},{"key":"R5-14-20210131","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":". Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.","volume":"367","author":"Baeten","year":"2012","journal-title":"N Engl J Med"},{"key":"R6-14-20210131","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":". Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"R7-14-20210131","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":". Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.","volume":"329","author":"Abdool Karim","year":"2010","journal-title":"Science"},{"key":"R8-14-20210131","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":". Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"key":"R9-14-20210131","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/428404","article-title":". Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.","volume":"191","author":"Flynn","year":"2005","journal-title":"J Infect Dis"},{"key":"R10-14-20210131","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1086\/508748","article-title":". Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.","volume":"194","author":"Pitisuttithum","year":"2006","journal-title":"J Infect Dis"},{"key":"R11-14-20210131","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":". Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"R13-14-20210131","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/S0140-6736(08)60920-4","article-title":". Effect of acyclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial.","volume":"371","author":"Celum","year":"2008","journal-title":"Lancet"},{"key":"R14-14-20210131","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa0904849","article-title":". Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.","volume":"362","author":"Celum","year":"2010","journal-title":"N Engl J Med"},{"key":"R15-14-20210131","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":". Preexposure prophylaxis for HIV infection among African women.","volume":"367","author":"Van Damme","year":"2012","journal-title":"N Engl J Med"},{"key":"R17-14-20210131","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/QAI.0b013e31825325aa","article-title":". Sexual risk behaviors, circumcision status, and preexisting immunity to adenovirus type 5 among men who have sex with men participating in a randomized HIV-1 vaccine efficacy trial: step study.","volume":"60","author":"Koblin","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R18-14-20210131","doi-asserted-by":"crossref","first-page":"F13","DOI":"10.1097\/QAD.0b013e3283522272","article-title":". Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention.","volume":"26","author":"van der Straten","year":"2012","journal-title":"AIDS"},{"key":"R19-14-20210131","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1016\/j.vaccine.2011.07.108","article-title":". Conceptual framework for behavioral and social science in HIV vaccine clinical research.","volume":"29","author":"Lau","year":"2011","journal-title":"Vaccine"},{"key":"R20-14-20210131","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1086\/209112","article-title":"Cognitive processes used by survey respondents to answer behavioral frequency questions.","volume":"14","author":"Blair","year":"1987","journal-title":"J Consumer Res"},{"key":"R22-14-20210131","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ajpa.20983","article-title":"How race becomes biology: embodiment of social inequality.","volume":"139","author":"Gravlee","year":"2009","journal-title":"Am J Phys Anthropol"},{"key":"R24-14-20210131","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jadohealth.2007.11.144","article-title":". Adolescent and adult participation in an HIV vaccine trial preparedness cohort in South Africa.","volume":"43","author":"Middelkoop","year":"2008","journal-title":"J Adolesc Health"},{"key":"R25-14-20210131","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/OLQ.0b013e318190191d","article-title":". HIV incidence rates and risk factors for urban women in Zambia: preparing for a microbicide clinical trial.","volume":"36","author":"Kapina","year":"2009","journal-title":"Sex Transm Dis"},{"key":"R26-14-20210131","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/aje\/153.7.619","article-title":". Are US populations appropriate for trials of human immunodeficiency virus vaccine The HIVNET Vaccine Preparedness Study.","volume":"153","author":"Seage","year":"2001","journal-title":"Am J Epidemiol"},{"key":"R27-14-20210131","doi-asserted-by":"crossref","first-page":"e24037","DOI":"10.1371\/journal.pone.0024037","article-title":". HIV incidence and risk factors for acquisition in HIV discordant couples in Masaka, Uganda: an HIV vaccine preparedness study.","volume":"6","author":"Ruzagira","year":"2011","journal-title":"PLoS One"},{"key":"R28-14-20210131","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/QAI.0b013e31817236ab","article-title":". The HVTN protocol 903 vaccine preparedness study: lessons learned in preparation for HIV vaccine efficacy trials.","volume":"48","author":"Djomand","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R29-14-20210131","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/00002030-199807000-00015","article-title":". Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States.","volume":"12","author":"Koblin","year":"1998","journal-title":"AIDS"},{"key":"R30-14-20210131","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/QAI.0b013e31815c71f7","article-title":". The value of site preparedness studies for future implementation of phase 2IIbIII HIV prevention trials: experience from the HPTN 055 study.","volume":"47","author":"Ramjee","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R31-14-20210131","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00126334-200302010-00008","article-title":". Randomized, controlled evaluation of a prototype informed consent process for HIV vaccine efficacy trials.","volume":"32","author":"Coletti","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R32-14-20210131","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00126334-200405010-00009","article-title":". Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation.","volume":"36","author":"Buchbinder","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R33-14-20210131","doi-asserted-by":"crossref","first-page":"e1474","DOI":"10.1371\/journal.pone.0001474","article-title":". SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria.","volume":"3","author":"Feldblum","year":"2008","journal-title":"PLoS One"},{"key":"R34-14-20210131","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1371\/journal.pone.0001312","article-title":". SAVVY (C31G) gel for prevention of HIV infection in women: a phase 3, double-blind, randomized, placebo-controlled trial in Ghana.","volume":"2","author":"Peterson","year":"2007","journal-title":"PLoS One"},{"key":"R36-14-20210131","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0140-6736(02)07816-9","article-title":"Blinding in randomised trials: hiding who got what.","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"R37-14-20210131","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0140-6736(02)07683-3","article-title":"Generation of allocation sequences in randomised trials: chance, not choice.","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"R38-14-20210131","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/01.qai.0000143600.41363.78","article-title":". HIV sexual risk behavior over 36 months of follow-up in the worlds first HIV vaccine efficacy trial.","volume":"39","author":"Bartholow","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R39-14-20210131","first-page":"298","article-title":"Invited commentary: condom effectiveness-will prostate-specific antigen shed new light on this perplexing problem Am J Epidemiol.","volume":"157","author":"Steiner","year":"2003","journal-title":""},{"key":"R40-14-20210131","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00007435-199705000-00005","article-title":"Validity of self-reported sexual behaviors in adolescent women using biomarker outcomes.","volume":"24","author":"Orr","year":"1997","journal-title":"Sex Transm Dis"},{"key":"R42-14-20210131","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1520\/JFS12042J","article-title":". Evaluation of prostate-specific antigen (PSA) membrane test assays for the forensic identification of seminal fluid.","volume":"44","author":"Hochmeister","year":"1999","journal-title":"J Forensic Sci"},{"key":"R44-14-20210131","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1473-3099(12)70088-9","article-title":". Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX BE: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144.","volume":"12","author":"Robb","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"R45-14-20210131","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10461-012-0333-8","article-title":". Adherence and acceptability in MTN 001: a randomized cross-over trial of daily oral and topical tenofovir for HIV prevention in women.","volume":"17","author":"Minnis","year":"2013","journal-title":"AIDS Behav"},{"key":"R46-14-20210131","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1007\/s10461-010-9799-4","article-title":". Real-time adherence monitoring for HIV antiretroviral therapy.","volume":"14","author":"Haberer","year":"2010","journal-title":"AIDS Behav"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAI.0b013e31829a3a4d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:02:29Z","timestamp":1620972149000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201307012-00014"}},"subtitle":["The Pivotal Role of Social and Behavioral Sciences in Trials of Biomedical HIV Prevention Interventions"],"short-title":[],"issued":{"date-parts":[[2013,7,1]]},"references-count":39,"journal-issue":{"issue":"Supplement 2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31829a3a4d","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7,1]]}}}